Skip to main content
TipRanks
Go Ultimate75% OFF

SUNWELS Co.,Ltd. (9229) AI Stock Analysis

2 Followers
JP:9229

SUNWELS Co.,Ltd.

(TSE/TYO:9229)

Select Model
Rating:38Underperform
Price Target:JPY 98.00â–¼(-6.67% Downside)
Action:reiterated
Date:11/07/26

The company faces severe financial distress with negative earnings, cash flow, and high leverage, which are the primary drivers of the low score. Technicals confirm a persistent downtrend, and the negative P/E ratio offers no valuation support. The overall risk profile is extremely high.

Positive Factors
Care-services business modelThe company operates in the long-term care and welfare domain, with revenue tied to ongoing service provision and facility operations. This service-based model can support business continuity because income is linked to recurring care activity rather than one-time product sales.
Negative Factors
Severe profitability deteriorationThe sharp decline in gross margin and move into operating losses show that revenue growth is not currently translating into earnings. Persistent cost pressure reduces the company’s ability to reinvest, absorb further operating disruption, or strengthen its financial position through internally generated profits.

SUNWELS Co.,Ltd. (9229) vs. iShares MSCI Japan ETF (EWJ)

-80%-60%-40%-20%0%20%40%JP:9229-76.56%EWJ+6.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 3.41B
Dividend Yield
―
Average Volume (3M)
276.62K
Price to Earnings (P/E)
-2.5
Beta (1Y)
1.05
Revenue Growth
7.75%
EPS Growth
49.71%
Country
Japan
Employees
3,570
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

SUNWELS Co.,Ltd. Business Overview & Revenue Model

Company Description

Sunwels Co., Ltd. primarily delivers nursing care services, with its operations prominently featuring the "PD house" model. The company runs specialized residential facilities for seniors diagnosed with Parkinson's disease and also manages a Kaatsu t...

How the Company Makes Money

SUNWELS generates revenue primarily by operating care and welfare services and charging fees associated with those services. Key revenue streams are expected to include (1) service fees from providing nursing care/welfare services (often structured a...

SUNWELS Co.,Ltd. Financial Statement Overview

Summary

Revenue growth is strong, but profitability has collapsed with negative margins and net losses. The balance sheet is highly leveraged (D/E 4.2x) with negative ROE, and operating cash flow has turned negative, raising severe liquidity and solvency concerns.

Income Statement

25Negative

Balance Sheet

20Very Negative

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue28.83B28.14B26.50B20.11B13.24B8.17B
Gross Profit2.74B2.76B4.89B5.13B3.24B1.60B
EBITDA2.01B1.88B1.88B3.15B1.52B573.94M
Net Income-1.49B-1.66B-925.00M802.00M303.60M10.65M
Balance Sheet
Total Assets45.05B45.63B39.44B31.74B19.30B9.10B
Cash, Cash Equivalents and Short-Term Investments3.93B4.09B5.64B3.31B2.61B814.76M
Total Debt29.03B29.11B22.49B20.11B11.20B6.60B
Total Liabilities38.63B38.66B30.82B26.54B14.69B8.52B
Stockholders Equity6.42B6.97B8.62B5.20B4.61B580.80M
Cash Flow
Free Cash Flow0-1.50B-2.32B-2.93B-740.86M-73.95M
Operating Cash Flow0-332.00M1.88B2.56B1.14B378.19M
Investing Cash Flow0-1.27B-4.40B-5.66B-2.04B-633.05M
Financing Cash Flow062.00M4.84B3.80B2.70B573.26M

SUNWELS Co.,Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price105.00

Price Trends

50DMA112.22Negative
100DMA120.44Negative
200DMA175.08Negative

Market Momentum

MACD-1.43Positive
RSI39.83Neutral
STOCH61.90Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9229, the sentiment is Negative. The current price of 105.00 is below the 20-day moving average (MA) of 111.60, below the 50-day MA of 112.22, and below the 200-day MA of 175.08, indicating a bearish trend. The MACD of -1.43 indicates Positive momentum. The RSI at 39.83 is Neutral, neither overbought nor oversold. The STOCH value of 61.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9229.

SUNWELS Co.,Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:9229 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9220JP:922070NeutralJPY 3.01B6.33―3.52%5.71%10.34%
JP:2373JP:237356NeutralJPY 5.18B17.93―4.46%4.76%-52.55%
JP:2425JP:242555NeutralJPY 2.50B27.76―3.42%-3.64%-66.52%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:7061JP:706149NeutralJPY 3.03B-28.15――6.75%-119.69%
JP:9229JP:922938UnderperformJPY 3.87B-2.52――7.75%49.71%

* Healthcare Sector Average

Performance Comparison

-60%-40%-20%0%JP:9229JP:2373JP:2425JP:7061JP:9220Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:9229 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:9229SUNWELS Co.,Ltd.105.00-343.00-76.56%
JP:2373Care Twentyone Corporation381.00-54.94-12.60%
JP:2425Care Service Co., Ltd.643.00-130.78-16.90%
JP:7061Japan Hospice Holdings Inc.337.00-944.94-73.71%
JP:9220FB CARE SERVICE CO.,LTD.1222.0024.072.01%

SUNWELS Co.,Ltd. Corporate Events

SUNWELS books extraordinary loss as voluntary retirement program trims care workforce

Sep 24, 2026

SUNWELS Co., Ltd. has completed a voluntary retirement program targeting non-managerial care, nursing and rehabilitation staff in designated areas, after receiving 231 applications and approving 112 employees to leave by October 31, 2026. Management...

SUNWELS Extends Loan Principal Deferral to Support Structural Reforms

Sep 24, 2026

SUNWELS Co., Ltd. has secured agreements with nine financial institutions to extend the deferral of principal repayments on its existing borrowings, pushing back payments originally due between October 1, 2026 and March 31, 2027. The deferral covers...

SUNWELS Launches Voluntary Retirement Program to Streamline Care Operations

Sep 1, 2026

SUNWELS Co., Ltd. has approved a voluntary retirement program as part of a broader effort to optimize personnel allocation in response to shifts in its earnings structure, including recent revisions to medical service fees. The initiative targets non...

Sunwels Names Former Health Ministry Official as President to Rebuild Trust

Aug 12, 2026

Sunwels Co., Ltd. has appointed Toshihiko Atarashi as President and Representative Director, signaling a leadership shift aimed at restoring trust and strengthening governance. Atarashi brings extensive experience from the Ministry of Health, Labour...

SUNWELS Narrows Quarterly Losses on Higher Sales but Keeps Zero-Dividend Outlook

Aug 12, 2026

SUNWELS reported non-consolidated net sales of ¥7,298 million for the three months ended June 30, 2026, up 10.5% year on year, while remaining loss-making with an operating loss of ¥347 million and a net loss of ¥557 million, improving from the previ...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026